Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: J Thorac Oncol. 2012 Sep;7(9):1361–1368. doi: 10.1097/JTO.0b013e318260e106

Table 3.

Independent Poor Prognostic Factors of Progression Free Survival

Patient Characteristics Hazard Ratio p-value Prog Score
Skin Metastasis 3.13 0.0001 103
No Bevacizumab (PC Alone) 1.52 <0.0001 37
Bone Metastasis 1.41 <0.0001 27
Liver Metastasis 1.40 0.0002 33
Low Serum Albumin (< LLN) 1.39 <0.0001 29
PS 1 (vs. PS 0) 1.21 0.01 19
Mediastinal Nodes 1.14 0.07 21